Orchid Pharma has received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection of the formulation manufacturing facility located at Plot Nos B5 (Pt) & B6 (Pt), SIPCOT Industrial Park, Irungattukottai, Sriperumbudur, Kancheepuram District in Tamil Nadu, India. The facility was inspected by USFDA in December 2016.
Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.